Familial antiphospholipid antibodies and acquired circulating anticoagulants

Lupus

Volumn 13, Issue 10, 2004, Pages 812-814

  ElHajj, I ^a   Uthman, I ^a   Chahel, A ^a   Khoury, F ^a   Arayssi, T ^a   Taher, Ali ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Factor IX inhibitor; Familial antiphospholipid syndrome; Platelet inhibitor; Prolonged bleeding time

Indexed keywords

ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 INHIBITOR; CYCLOPHOSPHAMIDE; DNA ANTIBODY; DOUBLE STRANDED DNA; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; PHOSPHOLIPID ANTIBODY; PREDNISONE; PROTEIN INHIBITOR; THROMBOCYTE SLOWING FACTOR; UNCLASSIFIED DRUG;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTHRITIS; ARTICLE; BRAIN ANGIOGRAPHY; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; CONFUSION; DIAGNOSTIC IMAGING; FAMILIAL DISEASE; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAGNETIC RESONANCE ANGIOGRAPHY; MEMORY DISORDER; PARTIAL THROMBOPLASTIN TIME; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROTEINURIA; RASH; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FACTOR IX; FEMALE; HUMANS; IMMUNOGLOBULINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS;

EID: 7644243106     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu1059cr     Document Type: Article

References (11)

1. Exner T, Barber S, Kronenberg H, Rickard KA. Familial association of the lupus anticoagulant. Br J Haematol 1980; 45: 89-96.
2. Arnett FC, Olsen ML, Anderson KL, Reveille JD. Molecular analysis of major histocompatibility complex alleles with the lupus anticoagulant. J Clin Invest 1991; 87: 1490-1495.
3. Goldberg SN, Conti-Kelly AM, Greco TP. A family study of anticardiolipin antibodies and associated clinical conditions. Am J Med 1995; 99: 473-479.
4. Asherson RA, Doherty DG, Vergani D, Khamashta MA, Hughes GRV. Major histocompatibility complex associations with primary antiphospholipid syndrome. Arthritis Rheum 1992; 35: 142-145.
5. Gastineau DA, Kazmier FJ, Nichols WL, Browie EJW. Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases. Am J Hematol 1985; 19: 265-275.
6. Hasselaar P, Derksen RHWM, Blokzijl L et al. Risk factors for thrombosis in lupus patients. Am Rheum Dis 1989; 48: 933-940.
7. Orlando E, Cortelazzo S, Marchetti M, Sanfratello R, Barbui T. Prolonged bleeding time in patients with lupus anticoagulant. Thromb Haem 1992; 68: 495-499.
8. Miller K, Neely JE, Krivit W, Edson JR. Spontaneously acquired factor IX in a nonhemophiliac child. J Pediatr 1978; 93: 232-234.
9. Castro O, Farber LR, Clyne LP. Circulating anticoagulants against factor IX and XI in systemic lupus erythematosus. Ann Intern Med 1972; 77: 543-548.
10. Shapiro SS, Hultin M. Acquired inhibitors to the blood coagulation factors. Semin Thromb Haem 1975; 1: 336.
11. Largo R, Sigg P, von Feiten A, Straub PW. Acquired factor IX inhibitor in a non hemophiliac patient with autoimmune diseases. Br J Haematol 1974; 26: 129-140.